{"id":1068477,"date":"2024-03-10T03:13:19","date_gmt":"2024-03-10T07:13:19","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/structure-therapeutics-to-present-at-leerink-partners-global-biopharma-conference\/"},"modified":"2024-08-18T11:47:48","modified_gmt":"2024-08-18T15:47:48","slug":"structure-therapeutics-to-present-at-leerink-partners-global-biopharma-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/structure-therapeutics-to-present-at-leerink-partners-global-biopharma-conference.php","title":{"rendered":"Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference"},"content":{"rendered":"<p><![CDATA[SAN FRANCISCO, March  08, 2024  (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced that Raymond Stevens, Ph.D., the Company\u2019s Founder and Chief Executive Officer, will participate in a fireside chat at the Leerink Partners Global Biopharma Conference on Wednesday, March 13, 2024, at 8:00 AM ET in Miami, Florida.]]><\/p>\n<p>See the article here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/03\/08\/2843321\/0\/en\/Structure-Therapeutics-to-Present-at-Leerink-Partners-Global-Biopharma-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference\">Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the article here: Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/structure-therapeutics-to-present-at-leerink-partners-global-biopharma-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068477","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068477"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068477"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068477\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}